Able Cerebral, Llc

Able Cerebral, LLC (ACL) is located in Ephrata, Pennsylvania, USA. ACL owns US, Canada and Chinese patents and patent applications. Innovation in technologies and therapeutic methods are among the core values of the company. ACL is a unique worldwide leader in timed brain energy delivery and circadian / chronotherapy for CNS diseases. ACL is currently transforming into a bio-pharmaceutical and medical device entity. ACL’s 1st innovative product BrainGlucose since 2013, has saved precious memories for Alzheimer's, diabetics, cancer patients on Chemo, and Parkinson's patients; the 2nd product under development AddMem (Alzheimer's disease & dementia Memory enhancing method) would be also a breakthrough therapeutic system (Device) in the world for memory retain and recovery for late stage Alzheimer's disease and Traumatic Brain Injury (TBI). ACL is proud to announce that, our first product BrainGlucose has gained great reputation within Alzheimer's patients and their caregivers. It stops AD patients nightmares, night sweats, and early morning hallucinations so they will not deteriorate to late stage and keep their dignity and relatively independent lifestyle. BrainGlucose has also been loved by many diabetics to prevent noctunal hypoglycemia (post midnight low blood sugar), and weight gain. ACL is actively seeking investment and joint ventures to co-develop our brain energy product and memory recovery project by applying for FDA approval as breakthrough drugs and non invasive medical device (AddMem).